Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations
- 9 August 2015
- journal article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 14 (6) , 770-776
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Extending the course of intravenous antibiotics in adult patients with cystic fibrosis with acute pulmonary exacerbationsChronic Respiratory Disease, 2012
- Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosisEuropean Respiratory Journal, 2011
- Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosisJournal of Cystic Fibrosis, 2011
- Location and Duration of Treatment of Cystic Fibrosis Respiratory Exacerbations Do Not Affect OutcomesAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbationsRespiratory Research, 2010
- Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary ExacerbationAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic FibrosisThe Journal of Pediatrics, 2007
- Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosisPediatric Pulmonology, 2002
- Impact of Recent Pulmonary Exacerbations on Quality of Life in Patients With Cystic FibrosisChest, 2002
- Predictive 5-Year Survivorship Model of Cystic FibrosisAmerican Journal of Epidemiology, 2001